跳至主要内容
临床试验/NCT01591980
NCT01591980撤回4 期

Effects of Perioperative Low-dose Pregabalin on Post-craniotomy Pain: A Two-centre Randomized Controlled Trial

Unity Health Toronto1 个研究点 分布在 1 个国家开始时间: 2013年8月最近更新:
适应症
干预措施
相关药物

试验速览

阶段
4 期
状态
撤回
试验地点
1
主要终点
Chronic post-craniotomy pain

研究概览

简要总结

Objective: To compare the incidence of chronic pain at 3 months among adults undergoing craniotomy between those received two different doses of pregabalin and those receiving placebo.

详细描述

Hypothesis

Perioperative pregabalin will reduce the incidence of chronic post-operative pain, and will reduce the opioid consumption, opioid-related side effects, and hospital length of stay compared with placebo in patients undergoing elective craniotomy.

Methods: 316 adults (18-65y), ASA I-III, undergoing elective craniotomy will be randomized to receive: 100mg or 150mg pregabalin or placebo once pre-operatively and 50mg or 75mg or placebo twice daily for 14 post-operative days. NRS pain scores, opioid consumption and side effects will be assessed up to 48h, and long-term pain at days 7, 14, 30, and 90. The primary analysis will involve the comparison between the 2 treatment groups together vs. placebo. A stepwise method will be used to evaluate the pairwise comparisons.

Outcomes: The primary outcome will be the incidence of chronic post-craniotomy pain at 3 mos. Important secondary outcomes are: neuropathic component of pain at 3 mos., total opioid consumption in the first 24h, and incidence and severity of opioid-related side effects at days 1, 2 and 7.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
18 Years 至 65 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Adults, 18 to 65 years (limited to 65 years to lower the risk of over-sedation for elderly patients)
  • Undergoing elective craniotomy (supratentorial or infratentorial) under general anaesthesia for: biopsy or resection of a tumour, clipping of an unruptured aneurysm, or excision of an arteriovenous malformation
  • ASA physical status I-III

排除标准

  • predicted need for prolonged post-operative ventilation (> 12 hours)
  • chronic pain secondary to previous craniotomy
  • known adverse reaction to drugs used (gabapentin, pregabalin, hydromorphone, and/or acetaminophen)
  • prior use of pregabalin or gabapentin (within 2 weeks before surgery)
  • current history of moderate to severe headaches (NRS ≥ 4) related to intracranial pathology (tumour pain) since it may be difficult to discriminate between ongoing tumour pain and surgery-related post-operative pain
  • current history of migraines
  • pre-existing chronic pain requiring chronic opioid use (30mg morphine equivalent within 4 weeks of surgery)
  • currently taking any drug that could interact with pregabalin
  • current history of alcohol or recreational drug abuse
  • known or suspected addiction to narcotic substances or chronic narcotic use in the last 2 weeks
  • history of malignant hyperthermia (contraindicates the anaesthesia protocol of this study)
  • history of angioedema
  • Body Mass Index ≤ 18.4 or ≥ 35
  • history of untreated obstructive sleep apnea
  • any condition that would contraindicate the use of patient-controlled analgesia (PCA)
  • lacks fluency in English
  • pre-existing renal impairment (for pregabalin elimination)
  • pregnancy

研究组 & 干预措施

Pregabalin 100 mg

Experimental

干预措施: pregabalin (Drug)

pregabalin 150 mg

Experimental

干预措施: pregabalin (Drug)

Placebo

Sham Comparator

干预措施: placebo (Drug)

结局指标

主要结局

Chronic post-craniotomy pain

时间窗: 3 months

The primary outcome of this study will be the incidence of chronic post-craniotomy pain at 3 months

次要结局

  • length of hospital stay(30 days)
  • neuropathic component of the pain at 3 months(3 months)
  • post-operative pain scores at 48h(48 hours)
  • incidence and severity of opioid-related side effects at day 2(Day 2)
  • incidence of long-term pain at days 7(Day 7)
  • incidence of long-term pain at day 14(Day 14)
  • incidence of long-term pain at day 30(Day 30)
  • total opioid consumption in the first 24h(24 hours)
  • total patient-controlled analgesia (PCA)demands and delivered doses in 24h(24 hours)
  • post-operative pain scores at 24h(24 hours)
  • incidence and severity of opioid-related side effects at Day 7(Day 7)
  • consumption of antiemetics in the first 24h(24 hours)
  • tracheal extubation time(within 24 hours)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验